You are here

  • Home
  • Archive
  • Volume 14, Issue Suppl 1
  • EFFICACY, PATTERNS OF RELAPSE AND SAFETY OF ADJUVANT TREATMENT WITH INTRAPERITONEAL (I.P.) YTTRIUM-90-LABELLED HMFG1 MONOCLONAL ANTIBODY (R1549) IN EPITHELIAL OVARIAN CANCER (EOC)

Article info

Article menu
Abstract
Free Communications
EFFICACY, PATTERNS OF RELAPSE AND SAFETY OF ADJUVANT TREATMENT WITH INTRAPERITONEAL (I.P.) YTTRIUM-90-LABELLED HMFG1 MONOCLONAL ANTIBODY (R1549) IN EPITHELIAL OVARIAN CANCER (EOC)

Authors

Citation

Massuger LF, Lopes A, Epenetos AA, et al
EFFICACY, PATTERNS OF RELAPSE AND SAFETY OF ADJUVANT TREATMENT WITH INTRAPERITONEAL (I.P.) YTTRIUM-90-LABELLED HMFG1 MONOCLONAL ANTIBODY (R1549) IN EPITHELIAL OVARIAN CANCER (EOC)
International Journal of Gynecologic Cancer 2004;14:16.
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2004 IGCS